APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pomalidomide Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pomalidomide Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025189 pages

Choose your research edition.

Industry ResearchPomalidomide Capsules Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pomalidomide Capsules Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Pomalidomide Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pomalidomide Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pomalidomide Capsules Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pomalidomide Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pomalidomide Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pomalidomide Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pomalidomide Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pomalidomide Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pomalidomide Capsules include Chia Tai Tianqing Pharmaceutical, Qilu Pharmaceutical, Natco Pharma, Hetero, Dr Reddy’s Laboratories, Bristol Myers Squibb, Apotex, Adalvo and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pomalidomide Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pomalidomide Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pomalidomide Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pomalidomide Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Pomalidomide Capsules Segment by Company

Chia Tai Tianqing Pharmaceutical

Qilu Pharmaceutical

Natco Pharma

Hetero

Dr Reddy’s Laboratories

Bristol Myers Squibb

Apotex

Adalvo

Abbott Laboratories

Pomalidomide Capsules Segment by Type

1mg per Unit

2mg per Unit

3mg per Unit

4mg per Unit

Pomalidomide Capsules Segment by Application

Kaposi Sarcoma

Multiple Myeloma

Pomalidomide Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pomalidomide Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pomalidomide Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pomalidomide Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pomalidomide Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pomalidomide Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pomalidomide Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pomalidomide Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pomalidomide Capsules Industry Trends Table 2. Pomalidomide Capsules Industry Drivers Table 3. Pomalidomide Capsules Industry Opportunities and Challenges Table 4. Pomalidomide Capsules Industry Restraints Table 5. Global Pomalidomide Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pomalidomide Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pomalidomide Capsules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pomalidomide Capsules Sales Market Share by Manufacturers Table 9. Global Pomalidomide Capsules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pomalidomide Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pomalidomide Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pomalidomide Capsules Manufacturers, Product Type & Application Table 13. Global Pomalidomide Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pomalidomide Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1mg per Unit Table 17. Major Manufacturers of 2mg per Unit Table 18. Major Manufacturers of 3mg per Unit Table 19. Major Manufacturers of 4mg per Unit Table 20. Global Pomalidomide Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Pomalidomide Capsules Sales by Type (2021-2026) & (K Units) Table 22. Global Pomalidomide Capsules Sales by Type (2027-2032) & (K Units) Table 23. Global Pomalidomide Capsules Sales Market Share by Type (2021-2026) Table 24. Global Pomalidomide Capsules Sales Market Share by Type (2027-2032) Table 25. Global Pomalidomide Capsules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Pomalidomide Capsules Revenue by Type (2021-2026) & (K Units) Table 27. Global Pomalidomide Capsules Revenue by Type (2027-2032) & (K Units) Table 28. Global Pomalidomide Capsules Revenue Market Share by Type (2021-2026) Table 29. Global Pomalidomide Capsules Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Kaposi Sarcoma Table 31. Major Manufacturers of Multiple Myeloma Table 32. Global Pomalidomide Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Pomalidomide Capsules Sales by Application (2021-2026) & (K Units) Table 34. Global Pomalidomide Capsules Sales by Application (2027-2032) & (K Units) Table 35. Global Pomalidomide Capsules Sales Market Share by Application (2021-2026) Table 36. Global Pomalidomide Capsules Sales Market Share by Application (2027-2032) Table 37. Global Pomalidomide Capsules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Pomalidomide Capsules Revenue by Application (2021-2026) & (K Units) Table 39. Global Pomalidomide Capsules Revenue by Application (2027-2032) & (K Units) Table 40. Global Pomalidomide Capsules Revenue Market Share by Application (2021-2026) Table 41. Global Pomalidomide Capsules Revenue Market Share by Application (2027-2032) Table 42. Global Pomalidomide Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Pomalidomide Capsules Sales by Region (2021-2026) & (K Units) Table 44. Global Pomalidomide Capsules Sales Market Share by Region (2021-2026) Table 45. Global Pomalidomide Capsules Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Pomalidomide Capsules Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pomalidomide Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Pomalidomide Capsules Sales by Country (2021-2026) & (K Units) Table 49. North America Pomalidomide Capsules Sales by Country (2027-2032) & (K Units) Table 50. Europe Pomalidomide Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Pomalidomide Capsules Sales by Country (2021-2026) & (K Units) Table 52. Europe Pomalidomide Capsules Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Pomalidomide Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Pomalidomide Capsules Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Pomalidomide Capsules Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Pomalidomide Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Pomalidomide Capsules Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Pomalidomide Capsules Sales by Country (2027-2032) & (K Units) Table 59. Global Pomalidomide Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pomalidomide Capsules Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pomalidomide Capsules Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pomalidomide Capsules Revenue Market Share by Region (2021-2026) Table 63. Global Pomalidomide Capsules Revenue Market Share by Region (2027-2032) Table 64. Chia Tai Tianqing Pharmaceutical Company Information Table 65. Chia Tai Tianqing Pharmaceutical Business Overview Table 66. Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Product Portfolio Table 68. Chia Tai Tianqing Pharmaceutical Recent Development Table 69. Qilu Pharmaceutical Company Information Table 70. Qilu Pharmaceutical Business Overview Table 71. Qilu Pharmaceutical Pomalidomide Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Qilu Pharmaceutical Pomalidomide Capsules Product Portfolio Table 73. Qilu Pharmaceutical Recent Development Table 74. Natco Pharma Company Information Table 75. Natco Pharma Business Overview Table 76. Natco Pharma Pomalidomide Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Natco Pharma Pomalidomide Capsules Product Portfolio Table 78. Natco Pharma Recent Development Table 79. Hetero Company Information Table 80. Hetero Business Overview Table 81. Hetero Pomalidomide Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Hetero Pomalidomide Capsules Product Portfolio Table 83. Hetero Recent Development Table 84. Dr Reddy’s Laboratories Company Information Table 85. Dr Reddy’s Laboratories Business Overview Table 86. Dr Reddy’s Laboratories Pomalidomide Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Dr Reddy’s Laboratories Pomalidomide Capsules Product Portfolio Table 88. Dr Reddy’s Laboratories Recent Development Table 89. Bristol Myers Squibb Company Information Table 90. Bristol Myers Squibb Business Overview Table 91. Bristol Myers Squibb Pomalidomide Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Bristol Myers Squibb Pomalidomide Capsules Product Portfolio Table 93. Bristol Myers Squibb Recent Development Table 94. Apotex Company Information Table 95. Apotex Business Overview Table 96. Apotex Pomalidomide Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Apotex Pomalidomide Capsules Product Portfolio Table 98. Apotex Recent Development Table 99. Adalvo Company Information Table 100. Adalvo Business Overview Table 101. Adalvo Pomalidomide Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Adalvo Pomalidomide Capsules Product Portfolio Table 103. Adalvo Recent Development Table 104. Abbott Laboratories Company Information Table 105. Abbott Laboratories Business Overview Table 106. Abbott Laboratories Pomalidomide Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Abbott Laboratories Pomalidomide Capsules Product Portfolio Table 108. Abbott Laboratories Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Pomalidomide Capsules Distributors List Table 112. Pomalidomide Capsules Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Pomalidomide Capsules Product Image Figure 2. Global Pomalidomide Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pomalidomide Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Pomalidomide Capsules Sales (2021-2032) & (K Units) Figure 5. Global Pomalidomide Capsules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pomalidomide Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1mg per Unit Image Figure 9. 2mg per Unit Image Figure 10. 3mg per Unit Image Figure 11. 4mg per Unit Image Figure 12. Global Pomalidomide Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Pomalidomide Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Pomalidomide Capsules Sales Market Share by Type (2021-2032) Figure 15. Global Pomalidomide Capsules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Pomalidomide Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Pomalidomide Capsules Revenue Market Share by Type (2021-2032) Figure 18. Kaposi Sarcoma Image Figure 19. Multiple Myeloma Image Figure 20. Global Pomalidomide Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Pomalidomide Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pomalidomide Capsules Sales Market Share by Application (2021-2032) Figure 23. Global Pomalidomide Capsules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Pomalidomide Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pomalidomide Capsules Revenue Market Share by Application (2021-2032) Figure 26. North America Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Pomalidomide Capsules Sales Market Share by Country (2021-2032) Figure 28. U.S. Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Pomalidomide Capsules Sales Market Share by Country (2021-2032) Figure 33. Germany Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Pomalidomide Capsules Sales Market Share by Country (2021-2032) Figure 40. China Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Pomalidomide Capsules Sales Market Share by Country (2021-2032) Figure 48. Brazil Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Pomalidomide Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Pomalidomide Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pomalidomide Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pomalidomide Capsules Revenue (2021-2032) & (US$ Million) Figure 59. North America Pomalidomide Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pomalidomide Capsules Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pomalidomide Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pomalidomide Capsules Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pomalidomide Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pomalidomide Capsules Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pomalidomide Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pomalidomide Capsules Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pomalidomide Capsules Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg per Unit
  • 2mg per Unit
  • 3mg per Unit
  • 4mg per Unit
Applications
  • Kaposi Sarcoma
  • Multiple Myeloma
Companies covered
  • Chia Tai Tianqing Pharmaceutical
  • Qilu Pharmaceutical
  • Natco Pharma
  • Hetero
  • Dr Reddy’s Laboratories
  • Bristol Myers Squibb
  • Apotex
  • Adalvo
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pomalidomide Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pomalidomide Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pomalidomide Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pomalidomide Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pomalidomide Capsules Market Dynamics
  1. 2.1 Pomalidomide Capsules Industry Trends
  2. 2.2 Pomalidomide Capsules Industry Drivers
  3. 2.3 Pomalidomide Capsules Industry Opportunities and Challenges
  4. 2.4 Pomalidomide Capsules Industry Restraints
3 Pomalidomide Capsules Market by Manufacturers
  1. 3.1 Global Pomalidomide Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pomalidomide Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pomalidomide Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pomalidomide Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pomalidomide Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pomalidomide Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Pomalidomide Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pomalidomide Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pomalidomide Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pomalidomide Capsules Tier 1, Tier 2, and Tier 3
4 Pomalidomide Capsules Market by Type
  1. 4.1 Pomalidomide Capsules Type Introduction
  2. 4.1.1 1mg per Unit
  3. 4.1.2 2mg per Unit
  4. 4.1.3 3mg per Unit
  5. 4.1.4 4mg per Unit
  6. 4.2 Global Pomalidomide Capsules Sales by Type
  7. 4.2.1 Global Pomalidomide Capsules Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pomalidomide Capsules Sales by Type (2021-2032)
  9. 4.2.3 Global Pomalidomide Capsules Sales Market Share by Type (2021-2032)
  10. 4.3 Global Pomalidomide Capsules Revenue by Type
  11. 4.3.1 Global Pomalidomide Capsules Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pomalidomide Capsules Revenue by Type (2021-2032)
  13. 4.3.3 Global Pomalidomide Capsules Revenue Market Share by Type (2021-2032)
5 Pomalidomide Capsules Market by Application
  1. 5.1 Pomalidomide Capsules Application Introduction
  2. 5.1.1 Kaposi Sarcoma
  3. 5.1.2 Multiple Myeloma
  4. 5.2 Global Pomalidomide Capsules Sales by Application
  5. 5.2.1 Global Pomalidomide Capsules Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pomalidomide Capsules Sales by Application (2021-2032)
  7. 5.2.3 Global Pomalidomide Capsules Sales Market Share by Application (2021-2032)
  8. 5.3 Global Pomalidomide Capsules Revenue by Application
  9. 5.3.1 Global Pomalidomide Capsules Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pomalidomide Capsules Revenue by Application (2021-2032)
  11. 5.3.3 Global Pomalidomide Capsules Revenue Market Share by Application (2021-2032)
6 Global Pomalidomide Capsules Sales by Region
  1. 6.1 Global Pomalidomide Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pomalidomide Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Pomalidomide Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Pomalidomide Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pomalidomide Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pomalidomide Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pomalidomide Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pomalidomide Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pomalidomide Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pomalidomide Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pomalidomide Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pomalidomide Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pomalidomide Capsules Revenue by Region
  1. 7.1 Global Pomalidomide Capsules Revenue by Region
  2. 7.1.1 Global Pomalidomide Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pomalidomide Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Pomalidomide Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Pomalidomide Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pomalidomide Capsules Revenue (2021-2032)
  8. 7.2.2 North America Pomalidomide Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pomalidomide Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Pomalidomide Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pomalidomide Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pomalidomide Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pomalidomide Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pomalidomide Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chia Tai Tianqing Pharmaceutical
  2. 8.1.1 Chia Tai Tianqing Pharmaceutical Company Information
  3. 8.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
  4. 8.1.3 Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Product Portfolio
  6. 8.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
  7. 8.2 Qilu Pharmaceutical
  8. 8.2.1 Qilu Pharmaceutical Company Information
  9. 8.2.2 Qilu Pharmaceutical Business Overview
  10. 8.2.3 Qilu Pharmaceutical Pomalidomide Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Qilu Pharmaceutical Pomalidomide Capsules Product Portfolio
  12. 8.2.5 Qilu Pharmaceutical Recent Developments
  13. 8.3 Natco Pharma
  14. 8.3.1 Natco Pharma Company Information
  15. 8.3.2 Natco Pharma Business Overview
  16. 8.3.3 Natco Pharma Pomalidomide Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Natco Pharma Pomalidomide Capsules Product Portfolio
  18. 8.3.5 Natco Pharma Recent Developments
  19. 8.4 Hetero
  20. 8.4.1 Hetero Company Information
  21. 8.4.2 Hetero Business Overview
  22. 8.4.3 Hetero Pomalidomide Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hetero Pomalidomide Capsules Product Portfolio
  24. 8.4.5 Hetero Recent Developments
  25. 8.5 Dr Reddy’s Laboratories
  26. 8.5.1 Dr Reddy’s Laboratories Company Information
  27. 8.5.2 Dr Reddy’s Laboratories Business Overview
  28. 8.5.3 Dr Reddy’s Laboratories Pomalidomide Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dr Reddy’s Laboratories Pomalidomide Capsules Product Portfolio
  30. 8.5.5 Dr Reddy’s Laboratories Recent Developments
  31. 8.6 Bristol Myers Squibb
  32. 8.6.1 Bristol Myers Squibb Company Information
  33. 8.6.2 Bristol Myers Squibb Business Overview
  34. 8.6.3 Bristol Myers Squibb Pomalidomide Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bristol Myers Squibb Pomalidomide Capsules Product Portfolio
  36. 8.6.5 Bristol Myers Squibb Recent Developments
  37. 8.7 Apotex
  38. 8.7.1 Apotex Company Information
  39. 8.7.2 Apotex Business Overview
  40. 8.7.3 Apotex Pomalidomide Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Apotex Pomalidomide Capsules Product Portfolio
  42. 8.7.5 Apotex Recent Developments
  43. 8.8 Adalvo
  44. 8.8.1 Adalvo Company Information
  45. 8.8.2 Adalvo Business Overview
  46. 8.8.3 Adalvo Pomalidomide Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Adalvo Pomalidomide Capsules Product Portfolio
  48. 8.8.5 Adalvo Recent Developments
  49. 8.9 Abbott Laboratories
  50. 8.9.1 Abbott Laboratories Company Information
  51. 8.9.2 Abbott Laboratories Business Overview
  52. 8.9.3 Abbott Laboratories Pomalidomide Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Abbott Laboratories Pomalidomide Capsules Product Portfolio
  54. 8.9.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pomalidomide Capsules Value Chain Analysis
  2. 9.1.1 Pomalidomide Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pomalidomide Capsules Production Mode & Process
  6. 9.2 Pomalidomide Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pomalidomide Capsules Distributors
  9. 9.2.3 Pomalidomide Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst